阿育吠陀药物所致铅中毒是成人腹痛的原因
该回顾性观察性病例系列来自印度一家三级医疗中心,纳入2005至2013年间因不明原因腹痛接受血铅检测的786例患者,血铅>25 μg/dl者75例(9.5%),其中73例(9.3%)有阿育吠陀药物服用史,仅2例为职业暴露。随机检测5种阿育吠陀药物均含铅量过高(14-34,950 ppm)。除腹痛外,表现还包括便秘、高血压、神经系统症状和急性肾损伤,73例均有贫血和肝功能生化异常。停用阿育吠陀药物并予d-青霉胺螯合治疗后,所有患者症状改善、血铅下降,历时3-4个月。
要点
- 不明原因腹痛患者中血铅>25 μg/dl者占9.5%(75/786),其中73例(9.3%)有阿育吠陀药物服用史。
- 随机检测的5种阿育吠陀药物铅含量均过高,范围14-34,950 ppm。
- 73例铅中毒患者均有贫血和肝功能生化异常,其他表现包括便秘、高血压、神经系统症状和急性肾损伤。
- 停用阿育吠陀药物并予d-青霉胺螯合治疗后,所有患者症状改善、血铅下降,历时3-4个月。
适用人群与场景
- 2005至2013年间在印度一家三级医疗中心因不明原因腹痛接受血铅检测的成人患者。
- 有阿育吠陀药物服用史的不明原因腹痛患者。
诊断标准与关键阈值
- 铅中毒定义为血铅水平(BLL)>25 μg/dl。
处置流程与药物剂量
- 停用阿育吠陀药物并予d-青霉胺螯合治疗,所有患者症状改善、血铅下降,历时3-4个月。
红旗征与不能漏的情况
- 严重反复腹痛伴贫血及阿育吠陀药物使用史者应评估铅中毒,早期诊断可避免不必要的检查和干预并尽早开始治疗。
研究设计与关键结果
- 回顾性观察性病例系列,来自印度一家三级医疗中心,786例不明原因腹痛患者中血铅>25 μg/dl者75例(9.5%)。
- 75例中73例(9.3%)有阿育吠陀药物服用史,仅2例为职业暴露。
- 随机检测5种阿育吠陀药物,铅含量均过高(14-34,950 ppm)。
- 73例患者除腹痛外,其他主诉包括便秘、高血压、神经系统症状和急性肾损伤;所有73例均有贫血和肝功能生化异常。
- 停用阿育吠陀药物并予d-青霉胺螯合治疗后,所有患者症状改善、血铅下降,历时3-4个月。
证据类型、等级与局限
- 证据类型:回顾性观察性病例系列。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对严重反复腹痛、贫血且有阿育吠陀药物使用史的患者应评估铅中毒,早期诊断可避免不必要的检查和干预,并尽早开始治疗。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Though a majority of cases of lead intoxication come from occupational exposures, traditional and folk remedies have also been reported to contain toxic amounts of lead. We present a large series of patients with lead poisoning due to intake of Ayurvedic medicines, all of whom presented with unexplained abdominal pain.
METHODOLOGY: This was a retrospective, observational case series from a tertiary care center in India. The charts of patients who underwent blood lead level (BLL) testing as a part of workup for unexplained abdominal pain between 2005 and 2013 were reviewed. The patients with lead intoxication (BLLs >25 μg/dl) were identified and demographics, history, possible risk factors, clinical presentation and investigations were reviewed. Treatment details, duration, time to symptomatic recovery, laboratory follow-up and adverse events during therapy were recorded.
RESULTS: BLLs were tested in 786 patients with unexplained abdominal pain and high levels were identified in 75 (9.5%) patients, of which a majority (73 patients, 9.3%) had history of Ayurvedic medication intake and only two had occupational exposure. Five randomly chosen Ayurvedic medications were analyzed and lead levels were impermissibly high (14-34,950 ppm) in all of them. Besides pain in abdomen, other presenting complaints were constipation, hypertension, neurological symptoms and acute kidney injury. Anemia and abnormal liver biochemical tests were observed in all the 73 patients. Discontinuing the Ayurvedic medicines and chelation with d-penicillamine led to improvement in symptoms and reduction in BLLs in all patients within 3-4 months.
CONCLUSION: The patients presenting with severe recurrent abdominal pain, anemia and history of use of Ayurvedic medicines should be evaluated for lead toxicity. Early diagnosis in such cases can prevent unnecessary investigations and interventions, and permits early commencement of the treatment.
参考来源
- Mehta V, Midha V, Mahajan R, et al. Lead intoxication due to ayurvedic medications as a cause of abdominal pain in adults. Clin Toxicol (Phila). 2016. PMID: 27957879. doi:10.1080/15563650.2016.1259474
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。